Literature DB >> 1037216

Effect of ethyl apovincaminate on cerebral circulation of dogs under normal conditions and in arterial hypoxia.

P Bencsáth, L Debreczeni, L Takács.   

Abstract

Effects of 1, 2 and 4 mg/kg i.v. doses of ethyl apovincaminate (RGH-4405, Cavinton) on cerebral blood flow, determined in the internal carotid and vertebral artery, were studied in anaesthetized dogs under 21, 16 and 11% O2 inhalation. Total cerebral blood flow was increased by 4 mg/kg Cavinton under normal O2 and between 100 to 200 mmHg perfusion pressures, while 2 mg/kg doses were effective under hypoxia. Similar phenomena were observed in the carotid and vertebral flow, separately. Arterial hypoxia seems to potentiate the effect of Cavinton on cerebral blood flow.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1037216

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  Psychopharmacological effects of vinpocetine in normal healthy volunteers.

Authors:  Z Subhan; I Hindmarch
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.

Authors:  P Miskolczi; K Kozma; M Polgár; L Vereczkey
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jan-Mar       Impact factor: 2.441

3.  Enhanced oral bioavailability of vinpocetine through mechanochemical salt formation: physico-chemical characterization and in vivo studies.

Authors:  Dritan Hasa; Dario Voinovich; Beatrice Perissutti; Mario Grassi; Alois Bonifacio; Valter Sergo; Cinzia Cepek; Michele R Chierotti; Roberto Gobetto; Stefano Dall'Acqua; Sergio Invernizzi
Journal:  Pharm Res       Date:  2011-03-19       Impact factor: 4.200

4.  Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid.

Authors:  P Miskolczi; L Vereczkey; L Szalay; C Göndöc
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.